Childhood cancers trials in Spain

In Spain 152 Also abroad 2459

152 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Where
Esplugues de Llobregat, Madrid
Age
Up to 17 years
People
18 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 · EU 2024-520125-36-00
No phaseTaking people
Exercise in Adolescents With Cancer
Where
Madrid, Villaviciosa de Odón
Age
12 years to 19 years
People
136
Run by
Universidad Europea de Madrid
See details and how to joinNCT05539794
Phase 2Taking people
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Where
Barakaldo, Barcelona, Bilbao, L'Hospitalet de Llobregat, Madrid, Oviedo, Pamplona, Salamanca, Santiago de Compostela, Terrassa, Valencia, Valladolid, Zaragoza
People
51
Run by
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
See details and how to joinNCT07717268
Phase 1/2Not yet taking people in Spain
Clinical trial on the use of modified immune cells (CART-NKG2D or NKIL15) administered into the central nervous system to treat aggressive brain tumors in children, adolescents, and young adults.
Where
Madrid
Age
Up to 64 years
People
30
Run by
Hospital Universitario La Paz
See details and how to join2026-525876-24-00 · EU 2026-525876-24-00
Phase 3Taking people
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Where
Barcelona, Madrid, Murcia, Pamplona
Age
12 years and over
People
400 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00
Phase 1/2Taking people
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Where
A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Logrono, Madrid, Málaga, Pozuelo de Alarcón
Age
12 years and over
People
361 worldwide
Run by
ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00
Phase 3Taking people
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Where
Barakaldo, Barcelona, Madrid, Murcia, San Cristóbal de La Laguna, Sevilla, Valencia, Zaragoza
People
508 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-505575-69-01 · EU 2023-505575-69-01
Phase 1/2Taking people
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Where
Barcelona, Madrid, Valencia
Age
Up to 18 years
People
472 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT02813135 · EU 2024-514791-40-00
Phase 3Taking people
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Where
Barcelona, L'Hospitalet de Llobregat, Pamplona
Age
16 years to 69 years
People
1,042 worldwide
Run by
University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00
Phase 2Taking people
Clinical trial of trabectedin, irinotecann and low-dose radiation therapy in advanced/metastatic sarcomas.
Where
Barcelona, La Laguna, Madrid, Valencia
People
92
Run by
Asoc Grupo Espanol De Investigacion En Sarcomas
See details and how to joinNCT05131386 · EU 2023-509215-81-00
No phaseTaking people
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Where
Barcelona, Elche, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Valencia, Valladolid
Age
12 years and over
People
4,975 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884
Phase 2/3Taking people
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
Where
Alicante, Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Málaga, Murcia, Oviedo, Palma, Pamplona, San Cristobal De La Laguna, Santiago De Compostela, Sevilla, Valencia, Zaragoza
Age
Up to 64 years
People
894 worldwide
Run by
Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00
Phase 1/2Taking people
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Where
Boadilla del Monte
Age
3 years and over
People
25
Run by
Fundación de investigación HM
See details and how to joinNCT06607692 · EU 2024-512613-40-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Barcelona, Madrid
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 2Taking people
Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
Where
Pamplona
Age
1 year to 25 years
People
39 worldwide
Run by
Clinica Universidad de Navarra, Universidad de Navarra
See details and how to joinNCT07424092 · EU 2024-515009-24-00
Phase 4Not yet taking people in Spain
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Where
Barcelona, Esplugues de Llobregat, Madrid
Age
Up to 18 years
People
136
Run by
Hospital Universitari Vall d'Hebron Research Institute
See details and how to joinNCT07590648
Phase 3Taking people
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Where
Barakaldo, Barcelona, Las Palmas de Gran Canaria, Madrid, Malaga, Murcia, Santander, Sevilla, Valencia, Zaragoza
Age
Up to 64 years
People
87 worldwide
Run by
Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00
Phase 1/2Taking people
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Where
Barcelona, Madrid, Sevilla, Valencia
Age
Up to 64 years
People
72 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 · EU 2023-504880-18-00
Phase 3Taking people
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Where
Alicante, Almería, Badajoz, Barakaldo, Barcelona, Donostia, Esplugues De Llobregat, Granada, Las Palmas de Gran Canaria, Madrid, Málaga, Murcia, Oviedo, Palma, Pamplona, Santa Cruz de Tenerife, Santander, Santiago de Compostela, Sevilla, Toledo, Valencia, Valladolid, Vigo, Zaragoza
Age
Up to 18 years
People
683 worldwide
Run by
University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00
No phaseNot yet taking people in Spain
Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
Where
Salamanca
People
75
Run by
University of Salamanca
See details and how to joinNCT07165912
No phaseTaking people
Thoracic Tumours Register
Where
A Coruña, Albacete, Alcalá de Henares, Alcázar de San Juan, Alcorcón, Alcoy, Alicante, Alzira, Aravaca, Badalona, Barcelona, Bilbao, Burgos, Cáceres, Cartagena, Castelló, Ciudad Real, Cuenca, Donostia / San Sebastian, Elche, Elda, Ferrol, Fuenlabrada, Girona, Granada, Granollers, Guadalajara, Jaén, Las Palmas de Gran Canaria, León, Lugo, Madrid, Málaga, Mataró, Móstoles, Murcia, Ourense, Palma de Mallorca, Pamplona, Parla, Pozuelo de Alarcón, Reus, Salamanca, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Segovia, Seville, Tarragona, Terrassa, Toledo, Tortosa, Tudela, Valencia, Valladolid, Vigo, Vitoria-Gasteiz, Xàtiva, Zamora
People
10,000
Run by
Spanish Lung Cancer Group
See details and how to joinNCT02941458
Phase 3Taking people
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Where
Barcelona, Esplugues de Llobregat, Madrid, Pamplona, Salamanca, Valencia
People
510 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00
No phaseTaking people
Luminal Breast Cancer Cryoablation
Where
Lugo
People
140
Run by
Lucía Graña López
See details and how to joinNCT07447414
Phase 2Taking people
Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Where
Barcelona, Madrid, Murcia, San Cristóbal de La Laguna, Valencia, Zaragoza
Age
16 years to 70 years
People
25
Run by
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
See details and how to joinNCT07032285 · EU 2024-511987-10-00
Phase 2/3Taking people
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Where
L'Hospitalet de Llobregat
Age
18 years and over
People
280 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00